Proliferative responses of a bovine leukemia virus-infected lymphoblastoid B-cell line by its culture supernatant and cytokines.

The growth-promoting activity in the culture supernatant of bovine lymphoblastoid B-cell lines (BL2M3 and BL312) were examined. BL2M3 cells proliferated well in response to conditioned medium (CM) obtained from BL2M3 and BL312 cell cultures. These BL2M3 and BL312 CM were used as sources of BL2M3 cell growth-promoting factor (BL2M3-GPF). BL2M3-GPF was sensitive to acid (pH 2) and alkali (pH 10) and was heat-labile. Proliferative responses of BL2M3 cells were not induced by human recombinant (r)IL 1, rIL 2, rIL 6, granulocyte-colony stimulating factor (rG-CSF) or tumor necrosis factor (rTNF)-alpha. Human low molecular weight B cell-growth factor (LMW-BCGF) was, however, capable of augmenting the proliferation of BL2M3 cells. BL2M3 cells formed clusters in response to LMW-BCGF, whereas they showed single and discete appearance in the presence of BL2M3-GPF. These results suggested that bovine lymphoblastoid B-cell lines might release and respond to the growth-promoting factor for in vitro proliferation of its own cell line, BL2M3.

[1]  F. Blecha,et al.  In vitro interactions of cytokines and bovine viral diarrhea virus in phytohemagglutinin-stimulated bovine mononuclear cells. , 1990, Veterinary immunology and immunopathology.

[2]  J. Cairns,et al.  The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23). , 1988, Immunology.

[3]  G. Guy,et al.  Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40) , 1988, European journal of immunology.

[4]  J. Gordon,et al.  Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Arai,et al.  B cell growth-promoting activity of recombinant human interleukin 4. , 1987, Journal of immunology.

[6]  S. Swendeman,et al.  The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.

[7]  S. Itohara,et al.  Establishment of bovine leukemia virus-producing and -nonproducing B-lymphoid cell lines and their proviral genomes. , 1987, Leukemia research.

[8]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[9]  S. Swendeman,et al.  Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens. , 1986, Journal of immunology.

[10]  R. Montagna,et al.  Purification of human B cell growth factor. , 1985, Journal of immunology.

[11]  S. Swain.  Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells. , 1985, Journal of immunology.

[12]  I. Ernberg,et al.  Capacity of B‐lymphocytic lines of diverse tumor origin to produce and respond to B‐cell growth factors: A progression model for B‐cell lymphomagenesis , 1985, International journal of cancer.

[13]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[14]  J. Gordon,et al.  Immortalized B lymphocytes produce B-cell growth factor , 1984, Nature.

[15]  P. Åman,et al.  Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus , 1984, The Journal of experimental medicine.

[16]  G. Todaro,et al.  Growth factors produced by sarcoma virus-transformed cells. , 1978, Cancer research.